Boston

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

4 hours ago   |   Xconomy

Perhaps the most talked-about news at the JP Morgan Healthcare Conference this week was a new startup that launched with $200 million and an ambitious claim its first drug...
Read more ...

Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference

Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference

1 day ago   |   Xconomy

Startup nference has closed a $60 million Series B financing round to expand the use of its augmented intelligence platform in clinical research and drug development. Mayo...
Read more ...

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

1 day ago   |   Xconomy

Neon Therapeutics closed 2019 by curtailing its cancer vaccine programs and laying off 24 percent of its workforce, part of a corporate restructuring aimed at finding a new...
Read more ...

Profs. Vajda and Paschalidis featured in Boston University ENGineer magazine

Profs. Vajda and Paschalidis featured in Boston University ENGineer magazine

2 days ago   |   BioMolecular Engineering

The Fall 2019 issue of the BU College of Engineering Magazine highlights the importance of cross-disciplinary collaborations in facilitating scientific discoveries. The title...
Read more ...

FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data

FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data

2 days ago   |   Xconomy

As the nation grapples with the ongoing opioid crisis, an FDA advisory panel on Tuesday unanimously voted against recommending approval of a Nektar Therapeutics painkiller that...
Read more ...

Schrödinger Sets Course for IPO to Support Growing Internal Pipeline

Schrödinger Sets Course for IPO to Support Growing Internal Pipeline

3 days ago   |   Xconomy

Scan the landscape of experimental medicines in development today and you'll spot Schrödinger's handiwork. The company's software has helped discover compounds that are now...
Read more ...

Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans

Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans

3 days ago   |   Xconomy

JP Morgan's annual healthcare conference convenes in San Francisco this week and Generation Bio CEO Geoff McDonough is betting gene therapy will be among the discussion topics...
Read more ...

Biogen Adds Another Neuro Drug to Pipeline in Deal With Pfizer

Biogen Adds Another Neuro Drug to Pipeline in Deal With Pfizer

3 days ago   |   Xconomy

Continuing to make headlines in the neurodegenerative disease space, Biogen on Monday announced a deal to acquire a clinical-stage Pfizer asset that has potential applications...
Read more ...

Akcea and Ionis Announce Initiation of CARDIO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with TTR-mediated Amyloid Cardiomyopathy

7 days ago   |   San Diego Biotechnology   |   2 articles

BOSTON and CARLSBAD, Calif., Jan. 10, 2020 - Akcea Therapeutics, Inc. , a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. , announced...
Read more ...

Biogen Teams Up With Startup CAMP4 to Scout for New Neuro Drugs

Biogen Teams Up With Startup CAMP4 to Scout for New Neuro Drugs

7 days ago   |   Xconomy

The next neuroscience drug that joins Biogen's pipeline might come from the research of startup CAMP4 Therapeutics. The two Cambridge, MA-based companies are starting an...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Perhaps the most talked-about news at the JP Morgan Healthcare Conference this week was a new startup that launched with $200 million and an ambitious claim its first drug... Read more ...

Trending News on Crop Biotech in 2019

Trending News on Crop Biotech in 2019

We summarized the top 10 most trending Crop Biotech Update news shared on social media to give you a glimpse of crop biotech happenings in 2019. Read on and make sure you don't... Read more ...

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

Neon Therapeutics closed 2019 by curtailing its cancer vaccine programs and laying off 24 percent of its workforce, part of a corporate restructuring aimed at finding a new... Read more ...

Event Announcement: Xcelerating Life Sciences San Diego

Event Announcement: Xcelerating Life Sciences San Diego

We're excited to announce the first in Xconomy's new Xcelerating Life Sciences event series convening local communities of innovators, executives, rising pioneers... Read more ...

Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference

Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference

Startup nference has closed a $60 million Series B financing round to expand the use of its augmented intelligence platform in clinical research and drug development. Mayo... Read more ...

How Breast Cancer Reunited Six High School Friends

How Breast Cancer Reunited Six High School Friends

Four of the six of us from my high school inner circle have had breast cancer over the past two years. And that has me wondering. Did a shared environmental exposure, stamped... Read more ...

Stepping into their own

Stepping into their own

Two Bond Life Sciences Center researchers find their path in teaching and research Sarah Unruh and Vinit Shanbhag have both taken paths that have led them toward teaching... Read more ...

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

Emendo Biotherapeutics, a company aiming to apply CRISPR gene editing to a wider range of genetic diseases, has raised $61 million in financing. The Series B round was led by... Read more ...

103395 Biorepository Assistant

CANCER CENTER/ Solid Tumor Therapeutics Salary commensurate with qualifications and experienceFiling Deadline: Fri 1/31/2020... Read more ...

Quantitative visualization of subcellular lignocellulose revealing the...

As a renewable carbon source, biomass energy not only helps in resolving the management problems of lignocellulosic wastes, but also helps to alleviate the global climate... Read more ...